These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19167639)

  • 21. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
    N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Atorvastatin on Th polarization in patients with acute myocardial infarction.
    Cheng X; Liao YH; Zhang J; Li B; Ge H; Yuan J; Wang M; Lu B; Liu Y; Cheng Y
    Eur J Heart Fail; 2005 Dec; 7(7):1099-104. PubMed ID: 15922660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
    [No Abstract]   [Full Text] [Related]  

  • 25. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
    Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.
    Jones PH; Goldberg AC; Knapp HR; Kelly MT; Setze CM; Stolzenbach JC; Sleep DJ
    Am Heart J; 2010 Oct; 160(4):759-66. PubMed ID: 20934572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV
    Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER; Hiatt WR; Creager MA
    Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    J Card Fail; 2008 Mar; 14(2):140-4. PubMed ID: 18325461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients.
    Guazzi M; Tumminello G; Reina G; Vicenzi M; Guazzi MD
    Eur J Clin Invest; 2007 Jun; 37(6):454-62. PubMed ID: 17537152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
    Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
    Am J Cardiol; 2004 Aug; 94(4):497-500. PubMed ID: 15325939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Miller M
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin].
    Raddino R; Della Pina P; Gorga E; Caretta G; Madureri A; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):78S-83S. PubMed ID: 21416832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.